Literature DB >> 1302279

Effects of vasopressin and angiotensin II on neurones in the rat dorsal motor nucleus of the vagus, in vitro.

Z L Mo1, T Katafuchi, H Muratani, T Hori.   

Abstract

1. Extracellular recordings were made from 297 spontaneously firing neurones in the dorsal motor nucleus of the vagus (DMV) in slice preparations of rat medulla oblongata. Some of the neurones recorded were identified to be vagal motoneurones by antidromic stimulation. The cells fired with a slow irregular pattern at an average rate of 1.1 +/- 0.1 spikes/s (mean +/- S.E.M.). 2. Arginine vasopressin (AVP) was applied by perfusion in 196 of the 297 cells. Most of the neurones (190/196, 97%) were excited by 10(-6) M AVP with an increase in firing rate from the basal level of 1.1 +/- 0.1 to a maximum of 2.5 +/- 0.2 spikes/s. There was a dose-dependent relation between the concentration of AVP and the increased firing rate in all DMV neurones tested (n = 38). The threshold concentration of the peptide to produce changes in firing rate was assumed to be about 10(-10) M. The remaining six neurones were not affected by application of AVP. 3. Application of oxytocin (OXT, 10(-6) M) increased the firing rate of all thirty-eight neurones tested. The effects of AVP and OXT on all neurones examined (n = 20 and 4, respectively) still persisted after blocking the synaptic transmission in a low-Ca2+ or Ca(2+)-free-high-Mg2+ solution, indicating the direct action of both AVP and OXT on the postsynaptic membranes. 4. The AVP-induced excitatory responses were completely but reversibly blocked by the V1-type receptor antagonists, [1-(beta-mercapto-beta, beta-cyclopentamethylene-propionic acid), 2-(O-methyl)tyrosine]-arginine vasopressin (d(CH2)5Tyr(Me)AVP) (n = 5) and Phaa-D-Tyr(Et)Phe-Gln-Asn-Lys-Pro-Arg-NH2 (n = 6), whereas a selective and reversible OXT receptor antagonist, desGly-NH2d(CH2)5[Tyr-(Me)2Thr4]ornithine vasotocin, which suppressed the OXT-induced excitation, did not block the responses to AVP (n = 11). 5. Application of angiotensin II (AII, 10(-6) M) to 153 neurones increased the firing rates of 60 (39%) neurones. The firing rate was increased from the basal level of 1.0 +/- 0.1 to a maximum of 1.8 +/- 0.2 spikes/s (n = 60). The effect of AII was completely abolished by an AII receptor antagonist, [Sar1,Ile8]angiotensin II (n = 6). There was a dose dependence of the excitatory response on AII concentration in all of eleven neurones tested. The threshold concentration was assumed to be about 10(-9) M. The activity of 5 (3%) of 153 neurones was decreased, and the remaining 88 (58%) neurones were not affected by AII.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1302279      PMCID: PMC1175172          DOI: 10.1113/jphysiol.1992.sp019434

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  25 in total

1.  Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin.

Authors:  M Manning; S Stoev; A Kolodziejczyk; W A Klis; M Kruszynski; A Misicka; A Olma; N C Wo; W H Sawyer
Journal:  J Med Chem       Date:  1990-11       Impact factor: 7.446

2.  Oxytocin excites gastric-related neurones in rat dorsal vagal complex.

Authors:  M J McCann; R C Rogers
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

3.  Immunohistochemical evidence for a neurophysin-containing autonomic pathway arising in the paraventricular nucleus of the hypothalamus.

Authors:  L W Swanson
Journal:  Brain Res       Date:  1977-06-10       Impact factor: 3.252

4.  Solid-phase synthesis of 16 potent (selective and nonselective) in vivo antagonists of oxytocin.

Authors:  M Manning; M Kruszynski; K Bankowski; A Olma; B Lammek; L L Cheng; W A Klis; J Seto; J Haldar; W H Sawyer
Journal:  J Med Chem       Date:  1989-02       Impact factor: 7.446

Review 5.  Arginine vasopressin as a central neurotransmitter.

Authors:  C L Riphagen; Q J Pittman
Journal:  Fed Proc       Date:  1986-08

6.  Evidence for the release of vasopressin and oxytocin into cerebrospinal fluid: measurements in plasma and CSF of intact and hypophysectomized rats.

Authors:  J Dogterom; T B Van Wimersma Greidanus; D F Swabb
Journal:  Neuroendocrinology       Date:  1977       Impact factor: 4.914

7.  Vasopressin receptors of the vasopressor (V1) type in the nucleus of the solitary tract of the rat mediate direct neuronal excitation.

Authors:  M Raggenbass; E Tribollet; M Dubois-Dauphin; J J Dreifuss
Journal:  J Neurosci       Date:  1989-11       Impact factor: 6.167

8.  Area postrema and differential reflex effects of vasopressin and phenylephrine in rats.

Authors:  J D Peuler; G L Edwards; P G Schmid; A K Johnson
Journal:  Am J Physiol       Date:  1990-04

9.  The effects of noradrenaline on neurones in the rat dorsal motor nucleus of the vagus, in vitro.

Authors:  A Fukuda; T Minami; J Nabekura; Y Oomura
Journal:  J Physiol       Date:  1987-12       Impact factor: 5.182

10.  Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog.

Authors:  E R Lumbers; D I McCloskey; E K Potter
Journal:  J Physiol       Date:  1979-09       Impact factor: 5.182

View more
  7 in total

1.  Phenotypic traits of the hypothalamic PVN cells innervating airway-related vagal preganglionic neurons.

Authors:  Prabha Kc; Abere Karibi-Ikiriko; Cheryl F Rust; Annapurni Jayam-Trouth; Musa A Haxhiu
Journal:  Respir Physiol Neurobiol       Date:  2006-03-03       Impact factor: 1.931

Review 2.  The intricacies of the renin-angiotensin-system in metabolic regulation.

Authors:  Erin B Bruce; Annette D de Kloet
Journal:  Physiol Behav       Date:  2016-11-22

Review 3.  Calcium and Parkinson's disease.

Authors:  D James Surmeier; Paul T Schumacker; Jaime D Guzman; Ema Ilijic; Ben Yang; Enrico Zampese
Journal:  Biochem Biophys Res Commun       Date:  2016-08-30       Impact factor: 3.575

4.  Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous system.

Authors:  Annette D de Kloet; Lei Wang; Jacob A Ludin; Justin A Smith; David J Pioquinto; Helmut Hiller; U Muscha Steckelings; Deborah A Scheuer; Colin Sumners; Eric G Krause
Journal:  Brain Struct Funct       Date:  2014-11-27       Impact factor: 3.270

5.  Calcium entry induces mitochondrial oxidant stress in vagal neurons at risk in Parkinson's disease.

Authors:  Joshua A Goldberg; Jaime N Guzman; Chad M Estep; Ema Ilijic; Jyothisri Kondapalli; Javier Sanchez-Padilla; D James Surmeier
Journal:  Nat Neurosci       Date:  2012-09-02       Impact factor: 24.884

6.  Arginine Vasopressin Injected into the Dorsal Motor Nucleus of the Vagus Inhibits Gastric Motility in Rats.

Authors:  Jianping Zhu; Lanlan Chang; Jinlu Xie; Hongbin Ai
Journal:  Gastroenterol Res Pract       Date:  2015-12-30       Impact factor: 2.260

Review 7.  Calcium, Bioenergetics, and Parkinson's Disease.

Authors:  Enrico Zampese; D James Surmeier
Journal:  Cells       Date:  2020-09-08       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.